Cargando…
A Case of Nonsmall-Cell Lung Cancer with Anaphylaxis after 41 Courses of Pembrolizumab along with Adrenal Insufficiency as an Immune-Related Adverse Event
In this report, we present a case of nonsmall-cell lung cancer with anaphylaxis after 41 courses of pembrolizumab along with adrenal insufficiency as an immune-related adverse event (irAE). A 73-year-old man with no allergic disease started pembrolizumab for postoperative recurrence of lung cancer....
Autores principales: | Nakamura, Tomoaki, Imai, Ryosuke, Nishimura, Naoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941790/ https://www.ncbi.nlm.nih.gov/pubmed/36825102 http://dx.doi.org/10.1159/000526561 |
Ejemplares similares
-
Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency
por: Hanna, Ramy M., et al.
Publicado: (2018) -
Two Cases of Pembrolizumab-Induced Secondary Adrenal Insufficiency
por: Kanzaki, Akinori, et al.
Publicado: (2021) -
Cardiac tamponade and adrenal insufficiency due to pembrolizumab: a case report
por: Oristrell, Gerard, et al.
Publicado: (2018) -
Pembrolizumab-Induced Adrenal Insufficiency Presenting Eight Months After Cessation of Treatment
por: Zilberman, Stephanie, et al.
Publicado: (2023) -
A Case of Lung Adenocarcinoma with Long-Term Response after Late-Onset Pembrolizumab-Induced Acute Adrenal Insufficiency
por: Sonehara, Kei, et al.
Publicado: (2021)